Table 2.
Observed and expected numbers of deaths and standardized mortality ratio (SMR) for overall and cause-specific deaths among 1,803 Yucheng subjects, from January 1, 1980 to December 31, 2008.
| Cause of death (ICD 9) | Males | Females | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| O | E | SMR (95% CI) | O | E | SMR (95% CI) | O | E | SMR (95% CI) | |
|
|
|||||||||
| All causes (001–999) | 178 | 143.9 | 1.2 (1.2–1.4) | 117 | 105.4 | 1.1 (0.9–1.3) | 295 | 248.9 | 1.2 (1.1–1.3) |
| Infectious and parasitic diseases (001–139) | 9 | 6.0 | 1.5 (0.7–2.8) | 2 | 3.5 | 0.6 (0.1–1.9) | 11 | 9.4 | 1.2 (0.6–2.0) |
| Neoplasms (140–239) | 46 | 36.4 | 1.3 (0.9–1.7) | 21 | 26.4 | 0.8 (0.5–1.2) | 67 | 62.6 | 1.1 (0.8–1.4) |
| Malignant neoplasm of liver and intrahepatic bile ducts(155) | 4 | 9.0 | 0.4 (0.1–1.1) | 6 | 2.8 | 2.1 (0.9–4.5) | 10 | 11.7 | 0.9 (0.4–1.5) |
| Malignant neoplasm of trachea, bronchus and lung (162) | 10 | 6.5 | 1.5 (0.8–2.7) | 1 | 2.8 | 0.4 (0.0–1.7) | 11 | 10.2 | 1.1 (0.6–1.9) |
| Malignant neoplasm of stomach (151) | 7 | 2.0 | 3.5 (1.5–7.0) | 1 | 2.0 | 0.5 (0–2.5) | 8 | 4.0 | 2.0 (0.9–3.8) |
| Malignant neoplasm of lymphatic and haematopoietic tissue (200–208) | 5 | 1.7 | 3.0 (1.1–6.6) | 0 | 1.6 | -- | 5 | 3.3 | 1.5 (0.6–3.4)) |
| Malignant neoplasm of thyroid gland (193) | 0 | 0 | -- | 2 | 1.0 | 2.0 (0.3–6.7) | 2 | 0.9 | 2.2 (0.4–7.2) |
| Malignant neoplasm of female breast (174) | 0 | 0 | -- | 4 | 3.6 | 1.1 (0.4–2.7) | -- | -- | -- |
| Endocrine, nutritional, and metabolic diseases and immunity disorders (240–279) | 7 | 10.3 | 0.7 (0.3–1.3) | 11 | 9.7 | 1.1 (0.6–2.0) | 18 | 20.0 | 0.9 (0.5–1.4) |
| Diabetes mellitus (250) | 3 | 9.4 | 0.3 (0.1–0.9) | 9 | 9.5 | 1.0 (0.5–1.7) | 12 | 19.0 | 0.6 (0.3–1.1) |
| Mental disorders (290–319) | 0 | 1.3 | -- | 0 | 0.3 | -- | 0 | 1.3 | -- |
| Diseases of the nervous system and sense organs (320–389) | 1 | 1.9 | 0.5 (0.0–2.6) | 1 | 1.6 | 0.6 (0.0–3.2) | 2 | 3.5 | 0.6 (0.1–1.9) |
| Disease of the circulatory system (390–459) | 38 | 32.0 | 1.2 (0.9–1.6) | 33 | 22.2 | 1.5 (1.0–2.1) | 71 | 54.5 | 1.3 (1.0–1.6) |
| Acute myocardial infarction (410) | 8 | 2.4 | 3.3 (1.6–6.4) | 3 | 3.2 | 0.9 (0.2–2.5) | 11 | 5.6 | 2.0 (1.0–3.4) |
| Other forms of heart disease (420–429) | 11 | 5.0 | 2.2 (1.2–3.8) | 9 | 3.7 | 2.4 (1.2–4.5) | 20 | 8.7 | 2.3 (1.4–3.5) |
| Cardiac dysrhythmias (427) | 1 | 0.3 | 3.0 (0.1–14.4) | 3 | 0.3 | 9.6 (2.4–26.0) | 4 | 0.7 | 5.8 (1.8–13.9) |
| Late effects of cerebrovascular disease (438) | 3 | 1.8 | 1.7 (0.4–4.5) | 4 | 0.7 | 5.4 (1.7–13.1) | 7 | 2.4 | 2.9 (1.3–5.7) |
| Diseases of the respiratory system (460–519) | 7 | 9.7 | 0.7 (0.3–1.4) | 7 | 7.2 | 1.0 (0.4–1.9) | 14 | 16.7 | 0.8 (0.5–1.4) |
| Disease of the digestive system (520–579) | 23 | 12.1 | 1.9 (1.2–2.8) | 9 | 11.8 | 0.8 (0.4–1.4) | 32 | 24.1 | 1.4 (0.9–1.9) |
| Chronic liver disease and cirrhosis (571) | 16 | 6.5 | 2.5 (1.5–3.9) | 3 | 5.9 | 0.5 (0.1–1.4) | 19 | 12.4 | 1.5 (1.0–2.3) |
| Disease of the genitourinary system (580–629) | 6 | 3.7 | 1.6 (0.7–3.4) | 6 | 6.2 | 1.0 (0.4–2.0) | 12 | 9.9 | 1.2 (0.7–2.1) |
| Diseases of the skin and subcutaneous tissue (680–709) | 1 | 0.3 | 3.1 (0.2–15.4) | 0 | 0.9 | -- | 1 | 1.2 | 0.8 (0.0–4.2) |
| Diseases of the musculoskeletal system and connective tissue (710–739) | 1 | 0.7 | 1.4 (0.1–6.7) | 6 | 0.4 | 16.5 (6.7–34.3) | 7 | 1.1 | 6.4 (2.8–12.7) |
| Systemic lupus erythematosus (710) | 1 | 0 | -- | 5 | 0 | -- | 6 | 0 | -- |
| Symptoms, signs, and ill-defined conditions (780–799) | 8 | 8.6 | 1.0 (0.4–1.8) | 7 | 4.9 | 1.4 (0.6–2.8) | 15 | 13.2 | 1.1 (0.7–1.8) |
| Injury and poisoning (800–999) | 27 | 18.5 | 1.5 (1.0–2.1) | 12 | 9.0 | 1.3 (0.7–2.3) | 39 | 27.3 | 1.4 (1.0–1.9) |
ICD-9: International Classification of Diseases, ninth revision; O: Observed numbers; E: Expected numbers 95% CI=95% confidence interval calculated based on Mid-P tests; Bolded text: The ratio of Yucheng observed number of deaths over expected number of deaths is significant.